Drugs Affecting the Autonomic Nervous System
The autonomic nervous system (ANS) controls involuntary functions like heart rate, digestion, and blood pressure. Drugs that target this system work by interacting with specific receptors, either mimicking or blocking the natural neurotransmitters acetylcholine and norepinephrine. Understanding these drug classes is essential because they form the basis for treating conditions ranging from asthma to hypertension.
Drug Classes in the Autonomic System
There are two major neurotransmitter pathways in the ANS, and drugs are organized around which pathway they target and whether they activate or block it.
Cholinergic drugs act on acetylcholine (ACh) receptors and come in two main forms:
- Acetylcholine receptor agonists bind to ACh receptors and mimic its effects. Bethanechol, for example, stimulates bladder contraction and is used to treat urinary retention.
- Acetylcholinesterase inhibitors don't mimic ACh directly. Instead, they prevent the enzyme acetylcholinesterase from breaking ACh down, so more ACh accumulates at the synapse. Neostigmine works this way and is used to treat myasthenia gravis.
Anticholinergic drugs block ACh from binding to its receptors. Atropine is a classic muscarinic receptor antagonist. It blocks ACh at muscarinic receptors, which increases heart rate and reduces secretions. You'll often see it used before surgery or to treat bradycardia.
Adrenergic drugs act on adrenergic receptors (alpha and beta) and fall into two categories:
- Sympathomimetic drugs mimic or enhance sympathetic activity. These can work in three ways:
- Direct-acting: bind directly to adrenergic receptors (phenylephrine stimulates alpha-1 receptors, causing vasoconstriction)
- Indirect-acting: increase norepinephrine release or prevent its reuptake (amphetamine)
- Mixed-acting: do both (ephedrine)
- Sympatholytic drugs block sympathetic activity by antagonizing adrenergic receptors:
- Alpha-adrenergic antagonists like prazosin block alpha receptors, reducing peripheral resistance and lowering blood pressure
- Beta-adrenergic antagonists like propranolol block beta receptors, decreasing heart rate and contractility
Cholinergic vs. Adrenergic Compounds
The easiest way to keep these straight is to remember which division of the ANS they correspond to. Cholinergic compounds produce parasympathetic ("rest and digest") effects, while adrenergic compounds produce sympathetic ("fight or flight") effects.
| Effect | Cholinergic (Parasympathetic) | Adrenergic (Sympathetic) |
|---|---|---|
| Heart rate | Decreased (acetylcholine) | Increased (norepinephrine) |
| GI motility/secretion | Increased, promotes digestion (bethanechol) | Decreased, reduces digestion (epinephrine) |
| Pupils | Constriction / miosis (pilocarpine) | Dilation / mydriasis (phenylephrine) |
| Airways | Bronchoconstriction (methacholine) | Bronchodilation (albuterol) |
| Blood pressure | Generally decreased | Increased via vasoconstriction (dopamine) |
Notice the pattern: these two classes produce essentially opposite effects on every organ system. That's because the parasympathetic and sympathetic divisions normally oppose each other to maintain homeostasis.
Sympathomimetic vs. Sympatholytic Drugs
These two categories both target the sympathetic nervous system but push it in opposite directions.
Sympathomimetic drugs activate or enhance sympathetic responses. They stimulate adrenergic receptors directly or indirectly, leading to increased heart rate, elevated blood pressure, and bronchodilation. Common clinical uses include:
- Epinephrine for anaphylaxis and cardiac arrest
- Pseudoephedrine as a nasal decongestant (it causes vasoconstriction in nasal blood vessels)
- Treatment of hypotension, bradycardia, and bronchospasm
Sympatholytic drugs do the opposite. They block adrenergic receptors, dampening sympathetic output:
- Alpha-blockers (e.g., phentolamine) decrease blood pressure by reducing peripheral vascular resistance. They relax smooth muscle in blood vessel walls.
- Beta-blockers (e.g., atenolol) decrease heart rate and contractility, lowering both cardiac output and blood pressure.
- These drugs treat hypertension, tachycardia, and angina pectoris (chest pain caused by reduced blood flow to the heart).
A helpful way to remember: sympathomimetic = mimics the sympathetic system (activates it). Sympatholytic = lyses/breaks down the sympathetic response (blocks it).
Nicotine's Impact on Cardiovascular Control
Nicotine is a unique drug because it stimulates nicotinic acetylcholine receptors in both the autonomic ganglia and the adrenal medulla. When nicotinic receptors on the adrenal medulla are activated, the gland releases catecholamines (epinephrine and norepinephrine) into the bloodstream, triggering a widespread sympathetic response.
Acute effects of nicotine:
- Increased heart rate and blood pressure
- Vasoconstriction
- Increased cardiac output and myocardial oxygen demand
Chronic effects develop with long-term use. Nicotinic receptors become desensitized, but the cardiovascular damage accumulates:
- Atherosclerosis: arteries narrow and harden, reducing blood flow
- Coronary artery disease: reduced blood flow to the heart muscle
- Myocardial infarction: complete blockage of blood flow to part of the heart, causing tissue death
- Stroke: disrupted blood flow to the brain, leading to brain damage
Withdrawal effects reflect the removal of that chronic sympathetic stimulation. Heart rate and blood pressure decrease, and parasympathetic activity becomes more dominant. This is why people quitting nicotine often feel sluggish or experience changes in digestion.
Neurotransmission in the Autonomic Nervous System
A few foundational concepts tie all of these drug classes together:
The ANS relies on two primary neurotransmitters: acetylcholine (used by all preganglionic neurons and parasympathetic postganglionic neurons) and norepinephrine (used by most sympathetic postganglionic neurons). Every drug discussed above works by either mimicking, enhancing, or blocking one of these two molecules at its receptor.
Cholinesterase is the enzyme responsible for breaking down acetylcholine in the synaptic cleft. This is why acetylcholinesterase inhibitors (like neostigmine) increase cholinergic activity: they prevent this breakdown, allowing ACh to linger and keep stimulating its receptors.
Adrenergic receptors (alpha-1, alpha-2, beta-1, beta-2) are the targets for norepinephrine and epinephrine. The specific receptor subtype determines the tissue response, which is why different sympathomimetic and sympatholytic drugs can have selective effects on the heart (beta-1) versus the airways (beta-2).
The blood-brain barrier limits the entry of many autonomic drugs into the central nervous system. This is clinically significant because it means most of these drugs primarily affect peripheral organs without altering brain function. Some drugs are specifically designed to cross or not cross this barrier depending on the desired effect.
Autonomic reflexes are the involuntary feedback loops that the ANS uses to regulate functions like blood pressure (the baroreceptor reflex) and heart rate. Drugs that alter autonomic signaling can disrupt these reflexes, which is why side effects like orthostatic hypotension (a sudden drop in blood pressure when standing) are common with many autonomic drugs.